Product NDC: | 51672-1308 |
Proprietary Name: | Clotrimazole and Betamethasone Dipropionate |
Non Proprietary Name: | Clotrimazole and Betamethasone Dipropionate |
Active Ingredient(s): | .64; 10 mg/mL; mg/mL & nbsp; Clotrimazole and Betamethasone Dipropionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LOTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-1308 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076493 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040728 |
Package NDC: | 51672-1308-3 |
Package Description: | 1 BOTTLE in 1 CARTON (51672-1308-3) > 30 mL in 1 BOTTLE |
NDC Code | 51672-1308-3 |
Proprietary Name | Clotrimazole and Betamethasone Dipropionate |
Package Description | 1 BOTTLE in 1 CARTON (51672-1308-3) > 30 mL in 1 BOTTLE |
Product NDC | 51672-1308 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clotrimazole and Betamethasone Dipropionate |
Dosage Form Name | LOTION |
Route Name | TOPICAL |
Start Marketing Date | 20040728 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE |
Strength Number | .64; 10 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |